New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5830 | K-(D-1-Nal)-FwLL-NH2 | High affinity and potent ghrelin receptor inverse agonist |
| 5808 | ISOX INACT | Negative control for PF-CBP1 (Cat. No. 5801) |
| 5327 | BGC 20-1531 hydrochloride | High affinity and selective EP4 antagonist |
| 5904 | Montelukast sodium | CysLT1 antagonist |
| 5902 | Tiotropium bromide | Potent muscarinic receptor antagonist |
| 5864 | Tolcapone | COMT inhibitor; also inhibits transthyretin aggregation |
| 5854 | SR 9238 | Potent and selective LXR inverse agonist |
| 5832 | TGX 221 | Potent and selective PI 3-kinase β inhibitor |
| 5817 | BSI 201 | PARP-1 inhibitor |
| 5754 | PF 543 hydrochloride | Potent and selective SphK1 inhibitor |
| 5714 | S 2101 | LSD1 inhibitor |